Conferences and Meetings on Oncology

Conference-Service.com offers, as part of our business activities, a directory of upcoming scientific and technical meetings. The calendar is published for the convenience of conference participants and we strive to support conference organisers who need to publish their upcoming events. Although great care is being taken to ensure the correctness of all entries, we cannot accept any liability that may arise from the presence, absence or incorrectness of any particular information on this website. Always check with the meeting organiser before making arrangements to participate in an event!

Meeting organisers can submit meetings free of charge for inclusion into the listing.

ALL COUNTRIES

1.
 
Keystone Symposia - Genomic Instability and DNA Repair
ID
825260
Dates
02 Apr 2017 - 02 Jun 2017
Location
Santa Fe, New Mexico, United States
Abstract
Genome stability is the foundation upon which all cellular and organismal processes depend. This conference will grapple with the intricate array of biochemical reactions orchestrated by the cell to replicate, repair and segregate chromosomes accurately despite constant threats from spontaneous and environmentally-induced damage. Defects in these reactions lead to genomic instability, a confirmed driver of cancer and degenerative diseases. Fascinating and therapeutically crucial questions remain about the mechanisms underlying chromosome stability, and cross-disciplinary approaches are required to address them. How do epigenetic chromatin marks influence repair of underlying DNA sequences, and how can we predict the effects of chemotherapeutic agents that alter such marks? To what extent is the nucleus organized into subdomains with distinct functions; how are these subdomains altered when cells move or differentiate? How are the myriad helicases, nucleases and polymerases coordinated to safeguard genome stability, why are these molecules often mutated in human disease, and how can we ameliorate the effects of such mutations? What is the array of strategies available to cancer cells as they achieve unlimited proliferation? This conference has a history of bringing together investigators from diverse subfields who otherwise rarely meet. Cutting-edge concepts in translational, genomic, cellular, molecular, RNA and structural biology will be dissected to take the conversation to unprecedented levels of depth and breadth. The concurrent conference on “DNA Replication and Recombination” will provide additional opportunities for cross-talk. Both conferences are committed to nurturing interactions among longtime experts in the field with students, postdocs and investigators new to the field.
Contact
Phone: [1 800-253-0685];     Email: info@keystonesymposia.org
Topics
Genomic Instability, DNA Repair, RNA Metabolism, Chromatin Structure, DNA Replication/Repair, Nuclear Dynamics, Cell Cycle Regulation, DNA Damage Response, Replication Coupled Repair, Telomeres, Centromeres
Related subject(s)
2.
 
APGCS — 4th Asia-Pacific Gastroenterology Cancer Summit
ID
854444
Dates
29 Apr 2017 - 30 Apr 2017
Location
Singapore, Singapore
Abstract
4th Asia-Pacific Gastroenterology Cancer Summit (APGCS) aims to bring forth updates and studies for GI Cancer prevalent in the Asia Pacific region and breakthroughs that have been achieved in the international field. The meeting is a conjoint effort by the Singapore Society to put an exciting, relevant and balanced programme that will cater to generalists and subspecialists alike.
Contact
Kris Olarte;     Phone: [+97143116300];     Email: apgcs@mci-group.com
Related subject(s)
Event website
3.
 
3RD INTERNATIONAL COLORECTAL CANCER SYMPOSIUM
ID
894003
Start date
03 May 2017
Location
London, United Kingdom
Abstract
Open to anyone involved in or interested in learning about the clinical trials co-ordinated by the Colorectal Cancer Multidisciplinary Research Group. A chance for collaborators, investigators and their teams to meet and exchange ideas. Confirmed speakers are Prof Angelita Habr-Gama, University of Sao Paolo, Brazil, Prof Cathy Eng, MD Anderson, Texas, USA, Prof Iris Nagtegaal, RUMCA, Netherlands, Dr Rodrigo Perez, University of Sao Paolo, Brazil, Mr Graham Branagan, Salisbury, UK. The featured trials are: TRIGGER, IMPRESS, SERENADE, MERCURY II, MINSTREL, 6 vs 12, Beyond TME, ctDNA, Deferral of Surgery, SOPRANO. The previous two symposia attracted an international audience which comprised the spectrum of disciplines involved in clinical trials both clinical and administrative and feedback given was that they were extremely beneficial and enjoyable days.
Contact
Professor Gina Brown;     Phone: [+44 (0) 20 8661 3964];     Email: gina.brown@rmh.nhs.uk
Topics
TRIGGER, IMPRESS, SERENADE, MERCURY II, MINSTREL, 6 vs 12, Beyond TME, ctDNA, Deferral of Surgery, SOPRANO, diagnostic imaging, oncology, radiology, gastrointestinal, surgery
Related subject(s)
4.
 
IMPAKT 2017 — IMPAKT Breast Cancer Conference 2017
ID
855655
Dates
04 May 2017 - 06 May 2017
Location
Brussels, Belgium
Abstract
The Breast International Group (BIG) and the European Society for Medical Oncology (ESMO), in collaboration with a multidisciplinary alliance of European breast cancer organisations, are pleased to confirm the IMPAKT 2017 Breast Cancer Conference, will be held in Brussels, Belgium, 4-6 May 2017. IMPAKT 2017 is designed for breast cancer researchers and clinicians who have a specific interest in translational research, new agents, molecular and functional diagnostics, biomarkers and cutting-edge research applications in the clinical setting.
Contact
Email: impakt@esmo.org
Topics
Detection, diagnosis, Early breast cancer systemic therapy, Loco-regional therapy, Advanced breast cancer, Genomics, proteomic analysis of breast cancer, Biomarkers, immunotherapy, Metastasis, Metastatic Breast Cancer, Imaging, Breast Cancer Biology, Preclinical Models, New drug development, Breast Cancer, Precision Medicine, Translational Research, ARN Sequencing, DNA Sequencing, Molecular Screening,
Event website
5.
 
Fusion Imaging: Whole - Body and Hybrid Imaging in Oncology
ID
882450
Dates
04 May 2017 - 06 May 2017
Location
Heidelberg, Germany
Abstract
The course is a 2 days immersion in hybrid techniques, learning about the possibilities and limits of whole-body MRI and whole-body CT, PET-CT, PET-MRI ranging from brain, head and neck tumors, lung cancer, lymphoma, melanoma, myeloma, gynaecological cancers. The faculty consists of distinguished professors from the German Cancer Research Center, University Hospital Heidelberg and University Hospital Bern.
Contact
Emese Polyak;     Phone: [+36 70 677 8851];     Email: info@adexilis.academy
Topics
radiology, imaging, mri, pet, ct, fusion, oncology, hybrid, course, workshop, Heidelberg, Germany
6.
 
Cancer Diagnostics 2017 — Cancer Diagnostics Conference & Expo
ID
854362
Dates
08 May 2017 - 10 May 2017
Location
Barcelona, Spain
Contact
Olivia James;     Phone: [702 508 8033];     Email: cancerdiagnosticsexpo2017@gmail.com
Related subject(s)
7.
 
7th EACR-OECI Joint Training Course: Molecular Pathology Approach to Cancer
ID
842309
Dates
08 May 2017 - 10 May 2017
Location
Amsterdam, Netherlands
Abstract
This course aims to provide a comprehensive overview of the state-of-the-art molecular pathology approaches and their application, and a discussion of current genomics and molecular pathology of solid malignancies. The course will provide knowledge beneficial for practising pathologists and oncologists, residents and fellows in pathology and oncology, and molecular biologists with interest in diagnostic and molecular pathology.
Contact
Kathryn Wass;     Email: kathryn.wass@nottingham.ac.uk
Topics
molecular pathology, precision medicine, genomic analyses, genetic determinants, tumourigenesis, cancer progression, genomics, solid malignancies, oncology, immunotherapy, parallel sequencing, breast cancer, transcriptomic, genetic biomarkers, endometrial cancers, melanoma, gastrointestinal stromal tumours, lung; colorectal, sarcomas, prostate, kidney, central nervous system
8.
 
Fortbildungsveranstaltung "Leitlinien-Update Onkologie": S3-Leitlinie Supportivtherapie
ID
877256
Start date
10 May 2017
Location
Berlin, Germany
Contact
Frau Juliane Truskowski (Projektbetreuung);     Phone: [03643 2468-129 (Büro Weimar)];     Email: juliane.truskowski@ng-akademie.de
Topics
DKG-Veranstaltung, S3-Leitlinie
9.
 
MOSM 2017 — Multidisciplinary Oncology Symposium Malaysia 2017
ID
880693
Dates
11 May 2017 - 14 May 2017
Location
Subang Jaya, Selangor, Malaysia
Abstract
The MOSM 2017 is unique in its multi-professional perspective to the scientific program because it will feature plenary sessions on latest developments and advancements in the next generation of cancer management. These topics encompass a wide range of related specialties and allied professions by renowned international and interventional radiologists, clinical oncologists, gastroenterologists, hepatologists, respiratory physicians, pathologists and many other specialists. The symposium is aimed to create a regional platform to meet and discuss issues of mutual interest. In addition, there will be a themed pre-congress live training workshop, namely “Masterclass in cTACE” which will focus on training of the advanced techniques in cTACE for Hepatocellular Carcinoma (HCC). The workshop objective is to provide a notable opportunity for exhaustive analysis as well as in-depth discussion on specific scopes of cTACE, supplementary to provide a training ground for the regional young IRs.
Contact
Nancy Tan;     Phone: [+6017-379-0000];     Email: nancy.tan@ramsaysimedarbyhealth.com
Topics
Masterclass Training Workshop with Live Case Telecast, Multidisciplinary Tumour Board Symposium & Case Studies, Leading Edge Procedures in the Management of Cancer: RFA, MWA, Cryotherapy, Nano Knife, Molecular & Immunohistochemical Pathology, 330 Degrees Fuse Endoscopy in Colon Cancer Screening, Insight Into Liver Cancer, Colorectal Carcinoma & Lung Cancer, Hybrid Angio-CT Guidance in Advanced Interventional Oncology, Transarterial Therapy & Management in Cancer, Novel Targeted & Immunotherapy in Cancer, Local Ablation in Malignant Disorders, New Cure in Hepatitis C, Interventional Radiology in the Treatment of Cancer Diseases, cTACE, Cancer Management, Hepatocellular Carcinoma, HCC, Liver Cancer, Lung cancer, Colorectal Cancer,
Related subject(s)
10.
 
iwCLL — XVII International Workshop on Chronic Lymphocytic Leukemia
ID
823337
Dates
12 May 2017 - 15 May 2017
Location
New York City, United States
Abstract
The International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biannual meeting focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders. Founded in 1979, iwCLL is now the largest international meeting dedicated to these blood cancers, leading the scientific discussion on both laboratory-based research and clinical practice. The biannual meeting provides a forum that facilitates the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and other lymphoproliferative disorders.
Contact
Kraig Steubing;     Phone: [1-888-476-9129];     Email: iwcll2017@bioascend.com
Topics
CLL, Lymphoproliferative Disorders
Related subject(s)
11.
 
2nd Annual Advances in Immuno-Oncology Congress
ID
842286
Dates
15 May 2017 - 16 May 2017
Location
London, United Kingdom
Abstract
Oxford Global are proud to present the 2nd Annual Advances in Immuno-Oncology Congress, taking place 15-16 May 2017 in London UK. The event features 200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies. 36 presentations and case studies will focus on the key developments in Immuno-Oncology with specific reference to the discovery of therapeutic areas, pre-clinical and clinical studies, screening, assays and modelling.The congress has 4 interactive streams: Discovery of Immuno-Oncology Therapies; Pre-clinical Immuno-Oncology; Screening, Assays and Modelling in Immuno-Oncology and Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials
Contact
Danielle Dalby;     Phone: [01865248455];     Email: d.dalby@oxfordglobal.co.uk
Topics
immuno-oncology, oncology, immunology, screening, assays, modelling
Related subject(s)
12.
 
Advancing Pathology For Cancer Diagnosis, Staging And Prognosis
ID
882256
Dates
16 May 2017 - 18 May 2017
Location
Online, United Kingdom
Abstract
Improving long-term survival rates in cancer remains a major global challenge. This event will bring together those involved at all stages of disease management from early detection in the GPs office to improved therapeutic interventions and disease monitoring. We will also showcase the latest in scientific research aimed at supporting this unmet clinical need.
Contact
Kristina Evangelou;     Phone: [+44 020 7183 82 31];     Email: cancer@euroscicon.com
Topics
cancer, oncology conference, carcinogen, cancer therapy, cancer therapeutics, cancer outcomes, cancer diagnosis
13.
 
AAMP Scottsdale — Clinical Chronic Disease & Oncology Conference
ID
880563
Dates
19 May 2017 - 21 May 2017
Location
Scottsdale, United States
Abstract
This 3 day conference is for MDs/NDs and DOs who are looking for advanced information on Integrative Medicine. There are so many conferences that just take you to the “basic level”, but having attended a number of conferences, this audience is for those who want information at the next level that can be applied in their clinical practice. 19.75 AMA PRA Category 1 credits available.
Contact
Sharon Phillips;     Phone: [9545401896];     Email: sharon@aampconferences.com
Topics
Integrative Medicine, chronic illness, genomics, cancer, environmental toxicants, infectious disease, autoimmunity, advanced therapy integration, IV Therapy, Hormonal, Hyperbarics, Diet and Hyperthermia
Related subject(s)
14.
 
FASEB SRC — Mitochondrial Biogenesis and Dynamics in Health, Disease and Aging
ID
876994
Dates
21 May 2017 - 26 May 2017
Location
West Palm Beach, Florida, United States
Abstract
The central role of mitochondria in normal cell physiology is evident from human diseases, including metabolic disorders and aging, which are associated with changes in mitochondrial function. This SRC will facilitate an exchange of knowledge and promote collaborative interactions between investigators that study basic aspects of mitochondria with translational investigators engaged in studying mitochondrial roles in human health, human diseases including age-associated disorders, and the aging process. Hence, this conference will gather basic and translational scientists with a broad range of research interests and different levels of experience ranging from established investigators to graduate students. A collegial format will facilitate discussions between all participants with the goal of bringing together their unique insights and integrate them into this rapidly expanding field.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
signaling, cancer, biochem, genetics, aging
15.
 
PMWC 2017 Duke — Precision Medicine World Conference 2017 Duke
ID
880567
Dates
24 May 2017 - 25 May 2017
Location
Durham, United States
Abstract
Co hosted by Stanford Health Care, UCSF, Intermountain Health, Duke University and Duke Health, the Precision Medicine World Conference (PMWC) formerly known as the Personalized Medicine World Conference is the only fully integrated conference to examine the advances and challenges of Personalized Medicine through a practical lens. PMWC brings together the thought-leaders of business, government, healthcare-delivery, research and technology into one information-rich, two-day conference.
Contact
Tomer Behar;     Email: tomer@pmwcintl.com
16.
 
American Society of Clinical Oncology 2017 Annual Meeting
ID
651366
Dates
02 Jun 2017 - 06 Jun 2017
Location
Chicago, United States
Abstract
Attendees of the 2017 Annual Meeting will find cutting-edge scientific presentations and comprehensive educational content. The ASCO Annual Meeting brings together more than 25,000 oncology professionals from a broad range of specialties, making it an excellent venue for exploring the theme of the Meeting — "Science and Society." Prospective attendees can familiarize themselves with some basic information, including: The various session types that will take place at the Annual Meeting, The Cancer Education and Scientific Program Committees.
Event website
17.
 
Training — Non Medical Prescribing in Cancer Care
ID
897045
Start date
05 Jun 2017
Location
London, United Kingdom
Abstract
This conference focuses on Non Medical Prescribing in Cancer Care. Through national updates and practical case studies the conference will demonstrate how the effective use of non medical prescribing in cancer care can improve patient care, experience and outcomes. The conference will focus on developing competence and confidence in non medical prescribing in cancer care, including using the new National Competency Framework for all Prescribers. Follow the conference on Twitter #NMPCancer A 20% discount is available by quoting ref: hcuk20c-s when booking.
Contact
8 Wilson Drive, Ottershaw, Surrey KT16 0NT;     Phone: 0044/1932 429933;     Email: kerry@hc-uk.org.uk
Topics
Non Medical Prescribing, Cancer, Oncology, Pharmacy, Medicine Management
18.
 
Fortbildungsveranstaltung "Leitlinien-Update Onkologie": S3-Leitlinie Palliativmedizin
ID
877213
Start date
09 Jun 2017
Location
Berlin, Germany
Contact
Frau Juliane Truskowski (Projektbetreuung);     Phone: [03643 2468-129 (Büro Weimar)];     Email: juliane.truskowski@ng-akademie.de
Topics
DKG-Veranstaltung, S3-Leitlinie
19.
 
FASEB SRC — Regulation and Function of Small GTPases
ID
871137
Dates
11 Jun 2017 - 16 Jun 2017
Location
West Palm Beach, Florida, United States
Abstract
This SRC provides an interactive forum that covers the latest developments in the small GTPase field and presents the newest technological advancements that are being used to unravel the complex roles of small GTPases in human health and disease. Small GTPases (e.g. Ras, Rac, Rho, Cdc42, Rab, Rap, Rheb and Ral) are essential for key cellular processes such as cell differentiation, proliferation, and migration, as well as the regulation of subcellular events such as vesicle trafficking. These critical functions of small GTPases make them important participants in a wide variety of physiological and pathophysiological processes. The founding member of the small GTPase superfamily, Ras, is the most commonly mutated oncogene in human cancers, and many other small GTPases (including RhoA, Rac1, Rab5, Rheb, and RalA) also play fundamental roles in cancer development and progression. Due to these important oncogenic functions of small GTPases, there is a strong cancer theme underlying this meeting. However, small GTPases also participate in other biomedically important events, including the promotion of vascular diseases, immunological abnormalities, mental disorders, and metabolic conditions. For these reasons, progress from a number of fields in addition to cancer biology will be highlighted, including neurobiology, developmental biology, computational biology, and membrane biophysics to ensure that we are leveraging and learning from discoveries made in important related fields. The main objective of the meeting is to stimulate cross-pollination of ideas among researchers investigating basic biochemical mechanisms, cell and tissue biology, and translational models to define the diverse functions of small GTPases.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
signaling, cell prolif &migration, cancer, physiology, biophysics
Related subject(s)
20.
 
FASEB SRC — GRKs and Arrestins: From Structure to Disease
ID
877043
Dates
11 Jun 2017 - 16 Jun 2017
Location
Saxtons River, VT, United States
Abstract
The overarching goal of the meeting is to bring together as many scientists working on diverse aspects of GRK/arrestin signaling as possible, in order to facilitate the exchange of novel findings and to stimulate the generation of new hypotheses, collaborations and approaches. The structural and functional mechanisms of GRKs and arrestins, as well as their roles in biased/non-canonical signaling by GPCRs, in the actions of drugs of abuse, in cardiovascular disease and in cancer will be major highlights of the meeting. Sessions devoted to these topics will foster further studies to combat addiction and disease with the ultimate objective of positively influencing human health. There are many opportunities available for attendees to give oral and poster presentations as well as optional recreational activities to foster the exchange of ideas and formulate new collaborations.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Related subject(s)
21.
 
Pancreatic Cancer 2017 — 2nd International Conference on Pancreatic Cancer & Liver Diseases
ID
853260
Dates
12 Jun 2017 - 13 Jun 2017
Location
London, United Kingdom
Abstract
Pulsus invites you to attend 2nd International Conference on Pancreatic Cancer & Liver Diseases (Pancreatic Cancer 2017) to be held in London, UK during June 12-13, 2017.We will be discussing in detail the anatomy, physiology, pathology and treatment of pancreatic diseases ranging from pancreatitis to pancreatic cancer in this conference. Speakers attending our conference are experts in the field and have been involved in research of novel techniques in the treatment of pancreatic ailments.
Contact
Sandra Johnson;     Phone: [+44-203-769-1765];     Email: sandraclinicalgastro@gmail.com
Topics
Pancreatic Cancer, Oncology, Pancreas, Gastroenterology, Hepatology, Medicine, Hepatitis, Vaccines, Liver Diseases, Fatty-acid liver diseases, Pharmaceutical drugs for pancreatic cancer, Pharmaceutical drugs for liver diseases, IPMN Pancreas
Related subject(s)
22.
 
SERGS — 9th Annual SERGS meeting
ID
876729
Dates
14 Jun 2017 - 16 Jun 2017
Location
Lille, France
Abstract
The 9th European annual meeting of SERGS will be held in LILLE, France on June 14-16, 2017. The CRG (the French surgical group in gynaecological robot-assisted laparoscopy) is pleased to organise this famous meeting for the second time, the first time being in Marseille in 2012. Our annual French meeting will also be associated with SERGS in 2017. For years, teams have worked diligently on developing mini-invasive surgery, especially in gynaecology. Mini-invasive surgery, which includes conventional, single-port and robot-assisted laparoscopy, is the referent surgical approach (e.g., in endometrial cancer) because of a significant decrease in early postoperative morbidity. The rate of mini-invasive surgery for gynaecologic oncology in France in 2012 was 37%. The decrease in the curve of laparotomy in gynaecologic oncology began in 2007–2008.
Contact
Lucie Lamlova;     Email: lucie.lamlova@sergsmail.org
Topics
Fast track surgery in gynaecology: laparoscopy, robot assisted laparoscopy and single port surgery.
Related subject(s)
Event website
23.
 
IMCO2017 — The 2nd International Meeting on CardiOncology
ID
876714
Dates
15 Jun 2017 - 16 Jun 2017
Location
Tel Aviv, Israel
Abstract
The 2nd International Meeting on CardiOncology will take place from 15-16 June, 2017 in Tel Aviv, Israel.

The main aims of this meeting are:

a) To establish and develop the field of cardio-oncology in Israel.

b) To bring together cardiologists, oncologists, hemato-oncologists and general practitioners from Israel and worldwide.

c) To bring together national and international medical and para-medical disciplines involved, including the fields of imaging, biomarkers and others.

d) To give stage for basic scientists and pharma companies involved in the development of novel antineoplastic treatments with potential for off-target cardiovascular effects.

e) To contribute to the development of international recommendations and guidelines in the field.

Don't miss the opportunity to join peers and key opinion leaders in Tel Aviv, Israel, 15-16 June, 2017. Get a head start, visit IMCO 2017 website.

Contact
Sarah Krein;     Phone: [+972 3 5767704];     Email: skrein@paragong.com
Topics
Cardioncology, Chemotherapy, Hematology, Cardiotoxicity, Cardiovascular Disease, Breast Cancer, Cardiology, Myocardial Infarction, Malignant Pericardial Effusion, AL Cardiac Amyloidosis, Heart Failure, Hematologic Cancer, Pediatric Cardio-oncology, Multiple Myeloma, Arrhythmia, Thrombosis, Thrombo-Prophylaxis, Pericardial Disease, Vascular Disease, Cardiovascular Risk Assessment, Cardiovascular Management, Pulmonary Hypertension, Imaging, Biomarkers, Radiation, Immunotherapy
Related subject(s)
24.
 
DEGRO 2017 — 23. Jahrestagung der Deutschen Gesellschaft für Radioonkologie
ID
841409
Dates
15 Jun 2017 - 18 Jun 2017
Location
Berlin, Germany
Contact
Annika Bleckert;     Phone: [030 204590];     Email: degro@mci-group.com
Topics
Radiooncology
25.
 
NGA Best of ASCO® Conference 2017
ID
877200
Dates
16 Jun 2017 - 17 Jun 2017
Location
Berlin, Germany
Abstract
Die NGA Best of ASCO® Conference 2017 ist die einzige von der ASCO® lizensierte Veranstaltung in Deutschland.
Contact
Frau Juliane Truskowski (Projektbetreuung);     Phone: [03643 2468-129 (Büro Weimar)];     Email: juliane.truskowski@ng-akademie.de
Topics
Best of ASCO, lizenzierte Veranstaltung,
26.
 
19th MCCR Workshop — ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research
ID
842241
Dates
17 Jun 2017 - 23 Jun 2017
Location
Zeist, Netherlands
Abstract
The ECCO-AACR-EORTC-ESMO Workshop on Methods in Clinical Cancer Research is an educational programme that introduces junior clinical oncologists in any oncology subspecialty to the principles of good clinical trial design.
Contact
Email: workshop@ecco-org.eu
Topics
Clinical trial design, Junior clinical oncologists, Oncology, Workshop
27.
 
FEBS Advanced Lecture Course on Oncometabolism: From Conceptual Knowledge to Clinical Applications
ID
870273
Dates
18 Jun 2017 - 24 Jun 2017
Location
Figueira da Foz, Portugal
Abstract
It is our great pleasure to invite you to the “FEBS Advanced Lecture Course on Oncometabolism: From Conceptual Knowledge to Clinical Applications”, which will be held in Figueira da Foz, Portugal, on 18-24 June, 2017. This 6-day course will provide the participants with a comprehensive overview of established and emerging topics in the fast growing field of oncometabolism. The scientific programme covers a wide range of topics, from basic concepts, to recent breakthroughs, advanced techniques and clinical applications.
Topics
Cancer, metabolism, oncometabolism
28.
 
DGPatho — 101. Jahrestagung der Deutschen Gesellschaft für Pathologie
ID
842284
Dates
22 Jun 2017 - 24 Jun 2017
Location
Erlangen, Germany
Contact
Phone: [030 204590];     Email: dgpatho@mci-group.com
Topics
Pathology, Genetics
Related subject(s)
29.
 
Ludwigshafener GastroTage 2017
ID
858132
Dates
23 Jun 2017 - 24 Jun 2017
Location
Ludwigshafen, Germany
Contact
Frau Felicitas Molnar;     Phone: [089/8906770];     Email: felicitas.molnar@cocs.de
Topics
Endoskopie, Sonographie, Endosonografie
Related subject(s)
Event website
30.
 
Onko 3-Länder-Update Spezial
ID
875440
Dates
23 Jun 2017 - 24 Jun 2017
Location
Munich, Germany
Abstract
Um den Onkologen im gesamten deutschsprachigen Raum die aktuellen Neuerungen im diagnostischen und therapeutischen Bereich der Onkologie kompakt zu vermitteln, wird der Onko 3-Länder-Update Spezial vom 23. – 24. Juni 2017 in München durchgeführt. Dabei informieren ausgewiesene Experten aus Deutschland, Österreich und der Schweiz über die aktuellen Trends der (inter)nationalen klinischen Onkologie-Therapie und -Forschung. Neben den wichtigsten chemo- und immun-therapeutischen Behandlungen von zahlreichen Organkrebsarten werden im Besonderen die Möglichkeiten und Herausforderungen innovativer diagnostischer Methoden fokussiert und im Plenum diskutiert.
31.
 
GI-Oncology 2017 - 13. Interdisziplinäres Update
ID
841381
Start date
24 Jun 2017
Location
Wiesbaden, Germany
Contact
Andreas Kandler;     Phone: [+49 (0)89 549096-77];     Email: gi-oncology@mci-group.com
Related subject(s)
32.
 
EACR-AACR-SIC 2017 Special Conference
ID
842261
Dates
24 Jun 2017 - 27 Jun 2017
Location
Florence, Italy
Abstract
Hosted by the European Association for Cancer Research (EACR), the American Association for Cancer Research (AACR) and the Italian Cancer Society (SIC), the EACR-AACR-SIC Special Conference 2017 “The Challenges of Optimising Immuno and Targeted Therapies: From Cancer Biology to the Clinic” will build on the success of the previous conference, which was widely praised for the quality of its programme and inspirational contributions. The conference format is designed to bring together basic, translational and clinical researchers, as well as researchers working on the development of new targeted therapeutics. Leading experts will present the latest achievements of multidisciplinary research dealing with drug action and resistance and highlight challenges that require a concerted multidisciplinary effort.
Contact
Email: EAS2017@ecco-org.eu
Topics
Oncology, Immunotherapy, Targeted therapies, Translational research, Clinical researcher, Targeted therapeutics, Drug resistance
33.
 
2nd DNA Replication as a Source of DNA Damage Conference
ID
814104
Dates
03 Jul 2017 - 06 Jul 2017
Location
Rome, Italy
Abstract
The maintenance of genome integrity is critical for the suppression of cancer and premature ageing. Only recently has it become appreciated that DNA replication stress is a crucial driver of genomic instability. The timely progression of replisomes can be disrupted by lesions and secondary structures in the template, by bound proteins and by conflicts with the transcription machinery. A prolonged pause of the replisome then exposes single stranded DNA, which, due to its recombinogenic nature, can lead to genome rearrangements, fragile site expression and cell death. Importantly, some cancers present excessive endogenous levels of replication stress, which can be exploited for their clearance. In this conference, we aim to bring together scientists studying DNA replication and repair, with those interested in how DNA damage can influence cancer and ageing.
Contact
Laura Trundle;     Email: laura@fusion-conferences.com
Topics
DNA Replication, DNA Damage, Cancer, Ageing
Related subject(s)
34.
 
Best of ASCO 2017
ID
883279
Dates
14 Jul 2017 - 16 Jul 2017
Location
Chandigarh, India
Abstract
The Best of ASCO® is an annual educational initiative that condenses highlights from ASCO's Annual Meeting every year. The Scientific committee will select specific abstracts for presentation, based on its relevance, impact on day to day practice and the needs of oncology professionals in India.
Contact
Dr. Gautam Goyal;     Phone: [+91-81958-49111];     Email: goyal_gautam@yahoo.com, bestofascoindia2017@yahoo.com
Topics
Recent advances in understanding of cancer genetics, diagnosis and cancer therapeutics. All cancers including gastrointestinal, genitourinary, gynaecological, lung, breast, brain cancer will be discusses. Hematological malignancies, pediatric cancers and others will be discussed by the eminent Medical, Radiation and Surgical Oncologists, Immuno-Oncologist, Palliative care specialists and social support providers. This conference will provide us the insight into the recent advances in cancer care.
35.
 
FASEB SRC — Hematologic Malignancies
ID
876932
Dates
23 Jul 2017 - 28 Jul 2017
Location
Saxtons River, VT, United States
Abstract
This SRC focuses on bringing together biochemists, geneticists, molecular biologists and clinicians interested in the pathophysiology of the leukemias and lymphomas, and the development of novel therapies for these diseases. Leukemia and lymphoma has provided a number of key paradigms for molecularly targeted cancer therapy, as illustrated by the remarkable success of all-trans-retinoic acid for the treatment of acute promyelocytic leukemia and tyrosine kinase inhibitor therapy for chronic myelogenous leukemia. New and promising small-molecule compounds and antibodies targeting epigenetic regulators, surface receptors and downstream signaling pathways are currently under development and will be discussed at this meeting. Added to these examples of targeted therapy, immunotherapy, including checkpoint inhibition and modified T cell-based therapies have emerged as important future anti-leukemia/lymphoma treatments.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
cancer, stem cell, hematology, genetics, molecular biology, lymphoma/leukemia
36.
 
Lancet Summit: COPD and Lung Cancer
ID
848766
Dates
28 Jul 2017 - 29 Jul 2017
Location
Perth, Australia
Contact
Marie-Claire Morley;     Email: m.morley@elsevier.com
Topics
This new Summit, organised by The Lancet Respiratory Medicine and The Lancet Oncology, will cover all of the main areas of debate for patients with COPD and lung cancer from prevention, diagnosis, treatment through to palliative care. It will also look at shared lessons from having a better understanding of the development and management of both diseases. Abstracts are invited by April 17, 2017 for presentation as posters to supplement the invited lectures on the following topics:  Prevention of COPD and lung cancer  Screening for COPD and lung cancer  Genetic insights into disease development  Disease management and current interventions  COPD and lung cancer: latest insights into treatment paradigms  Infectious complications in patient management  Latest advances in surgery and radiation  Post treatment and end of life care The conference will be of interest to clinicians, oncologists, researchers, nurses, policy makers, and public and global health advocates working in respiratory diseases and lung cancer.
Related subject(s)
37.
 
FASEB SRC — Protein Kinases and Protein Phosphorylation
ID
877138
Dates
06 Aug 2017 - 11 Aug 2017
Location
Cambridge, United Kingdom
Abstract
This conference focuses on the biology of protein kinases and phosphorylation signaling. Among FASEB’s longest-running SRCs, it brings together a dynamic international community of junior investigators, trainees, and established researchers from a field that is achieving startling new insight and medical breakthroughs. The program will link detailed understanding of protein structure and biochemical mechanism to control of large-scale processes like the cell division cycle, cell morphogenesis, and metabolism. This SRC will explore the field’s latest research, which is revealing surprising mechanisms of regulation, previously unappreciated subcellular organization, logic of pathways that coordinate diverse intracellular systems. Importantly, derangement of kinase signaling underlies disease, including cancer and diabetes. Drugs targeting kinases and phosphorylation have achieved dramatic cures and promise more, and the conference has consistently offered a robust platform for clinically important work.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
Pharmacology, Signaling, Molecular Biology, Biochem, Cancer
Related subject(s)
38.
 
FASEB SRC — Reversible Acetylation on Health and Disease (HDACs)
ID
871083
Dates
06 Aug 2017 - 11 Aug 2017
Location
Big Sky, Montana, United States
Abstract
Over the past few years, the “epigenetic” regulation of the genome has become increasingly important to understanding both the etiology and fundamental mechanisms of aging and age-related diseases. Key to epigenetic regulation are two classes of lysine-modifying enzymes, the histone deacetylases (sirtuins and HDACs) and the histone acetyltransferases (HATs). Both classes of enzyme are critical for maintaining youthful gene expression patterns, cell cycle progression, DNA repair, stem cells, mitochondria, cell fate, differentiation, cognition, energy utilization, and the pathogenesis of most age-related diseases. Alterations in sirtuin and HDAC function have been linked to neurodegenerative disorders, muscle wasting, cardiac hypertrophy, cancer, HIV infection, and more generally the process of aging. Several HDAC inhibitors have been approved by FDA to treat various cancers. Small molecule modulators of sirtuins are currently in clinical trials for the treatment of cancers, neuromuscular disorders, inflammatory and metabolic disorders. With particular relevance to aging, the sirtuins, a subclass of HDAC, were first identified in yeast genetic studies as regulators of lifespan and the health benefits of dietary restriction. Activation or overexpression of sirtuins have been shown to protect mice and primates from diseases of aging, and extend mean and maximum lifespan of mice. Therefore, a thorough understanding of sirtuins and HDACs is required, not merely for understanding the regulation of chromatin structure, gene regulation and protein function, but also because these enzymes are intimately involved in normal and abnormal cellular processes that greatly impact human health. Although targeting HATs for therapeutic purposes has been relatively slow compared to targeting deacetylases, exciting new progress has also been made in recent years. Importantly, targeting the bromodomains present in many HATs has attracted a lot of attention lately.
Contact
FASEB SRC Staff;     Phone: [3016347010];     Email: src@faseb.org
Topics
aging, stem cell, cancer, differentiation, structural biology
Related subject(s)
39.
 
ICAHO2017 — International Conference on Advances in Hematology and Oncology
ID
844170
Dates
12 Aug 2017 - 13 Aug 2017
Location
Coeur d'Alene, United States
Abstract
The goal of 5th International Conference on Advances in Hematology and Oncology (ICAHO 2017) is to improve the care of hematology and oncology patients by updating the hematology and oncology care providers about the new developments in the field. This ICAHO 2017 conference also provides attendees with opportunities to interact and network with top experts in hematology and oncology. We will have educational and scientific sessions.
Contact
Tara Shah;     Phone: [3605244696];     Email: support@binayfoundation.org
Topics
Cancer, Blood disease, Cancer research, Hematology, Oncology
Related subject(s)
40.
 
IPOS 2017 — 19th World Congress of Psycho-Oncology and Psychosocial Academy
ID
854353
Dates
14 Aug 2017 - 18 Aug 2017
Location
Berlin, Germany
Contact
Katharina Friedrich;     Phone: [+49 3643 2468-142];     Email: katharina.friedrich@kukm.de
Topics
Psychoonkologie, international, International Psycho-Oncology Society (IPOS), German Cancer Society (DKG), German Association of Psycho-Social Oncology (dapo), German Society of Medical Psychology (DGMP), German College of Psychosomatic Medicine (DKPM), German Society for Rehabilitation Sciences (DGRW), the German Association for Social Work in Health Care (DVSG) and the Federal Consortium for Psychosocial Counselling of Outpatients with Cancer (BAK).
Related subject(s)
Event website
41.
 
IMX — Immuno-Oncology Summit 2017
ID
897912
Dates
28 Aug 2017 - 01 Sep 2017
Location
Boston, MA, United States
Abstract
The Immuno-Oncology Summit will return to Boston again this August 28-September 1 with the goal of supporting researchers in developing the next generation of immunotherapies. Immuno-oncology researchers are changing the way we treat cancer by unleashing the immune system and achieving functional cures in some cancers. This year's IO Summit has been designed to give attendees a complete picture of the field and its advances with 12 conference tracks, 1 in-depth training seminar, and 4 instructional short courses. Topics include immunotherapy discovery, development, biomarkers, and translational oncology as well as emerging topic areas such as cancer vaccines, oncolytic viruses, and advances in synthetic biology techniques. Overall, this event provides a focused look at how researchers are applying new science and technology in the development of effective and safe immunotherapies.
Contact
Phone: [7819725400];     Email: chi@healthtech.com
Topics
Immunomodulatory Antibodies, Combination Immunotherapy, Techniques in Synthetic Biology, Immunology for Drug Discovery Scientists, Preclinical & Translational IO, Immuno-Oncology Targets, Adoptive T Cell Therapy, Quantitative Immune Profiling, Biomarkers for Immuno-Oncology, Oncolytic Virus Immunotherapy, Advances in Vaccine Technologies, Vaccine Adjuvants, Personalized Cancer Vaccines
Related subject(s)
42.
 
Gynecologic Cancers 2017 — 2nd International Congress on Contemporary Issues in Women Cancers and Gynecologic Oncology
ID
883135
Dates
29 Aug 2017 - 30 Aug 2017
Location
London, United Kingdom
Abstract
Gynecologic cancer is an uncontrolled growth of abnormal cells that originate from the reproductive organs. There are several types of Gynecologic cancer which include cervical, ovarian, uterine/endometrial, Vaginal and vulvar Cancer. 2nd International Congress on Contemporary Issues in Women Cancers and Gynecologic Oncology 2017 welcomes Gynecologists, Oncologists, Pathologists, Radiologists, Scientists, Research Associates, PhD scholars, Doctors, Nurse and Medical Professionals to be a part of the conference during August 29-30, 2017 London, UK
Contact
christine zoel;     Phone: [7025085200];     Email: zoelchristine@gmail.com
Related subject(s)
43.
 
5th SRC — 5th Singapore Rehabilitation Conference
ID
903450
Dates
07 Sep 2017 - 08 Sep 2017
Location
Singapore, Singapore
Abstract
The Singapore Rehabilitation Conference is the only regular general rehabilitation conference in Singapore and regionally. Topics are relevant across all levels of rehabilitation including Acute Hospitals, Community/Rehabilitation Hospitals and Community Rehabilitation Facilities. Clinicians, scientists, academics and administrators from Healthcare, Universities and the Industry will participate in this comprehensive programme. Programme hihglights include (1) strong contemporary focus on Geriatric & Cancer Rehabilitation relevant in rehab practice today, (2) covers established fields in Stroke, Spinal Cord, Traumatic Brain Injury, Cardiopulmonary & Musculoskeletal Rehabilitation including Hip Fractures, (3)Systems of Care including health services rehabilitation research, tele-rehabilitation and integrated care delivery and (4) Frontiers in Rehabilitation including ICU Rehab, Rehabilitation Technology, Brain Stimulation, Robotics and Virtual Reality.
Contact
5th SRC Organising Secretariat;     Phone: [+6565767658];     Email: src_secretariat@sgh.com.sg
Topics
Rehabilitation, Geriatric, Cancer, Stroke, Spinal Cord, Traumatic Brain Injury, Cardiopulmonary & Musculoskeletal Rehabilitation, Systems of Care, health services rehabilitation research, tele-rehabilitation, integrated care delivery, Rehabilitation Technology, Brain Stimulation, Robotics and Virtual Reality
44.
 
LBM2017 — London Breast Meeting 2017
ID
898883
Dates
07 Sep 2017 - 09 Sep 2017
Location
London, United Kingdom
Abstract
The international London Breast Meeting, now in its 4th year, has established itself as an essential meeting in the academic calendar, aiming to deliver an inspiring and thought-provoking programme in oncological, reconstructive and aesthetic breast surgery. This year we will be focusing on the new innovations in the field, including the topics of breast cancer treatment, robotics, implant technology, autologous reconstruction and aesthetic surgery.
Contact
Lisa Freeman;     Phone: [02075016762];     Email: lisa.freeman@markallengroup.com
Topics
Surgery, breast surgery, plastic surgery, reconstructive surgery, aesthetic surgery, oncology
Related subject(s)
45.
 
ESMO 2017 Congress
ID
799949
Dates
08 Sep 2017 - 12 Sep 2017
Location
Madrid, Spain
Abstract
“Integrating science into oncology for a better patient outcome.” In an era of deep understanding of the molecular biology underlying the development of cancer, it is crucial that researchers and clinicians exchange knowledge. The ESMO 2017 Congress, in partnership with EACR, will bring oncology professionals together to facilitate interaction and bridge knowledge sharing between the laboratory and clinic. The aim of ESMO 2017 is to work together, aligning the objectives of researchers and clinicians, in order to provide more precise direction leading to better treatment options for cancer patients. The ESMO Congress is  the  most influential annual meeting for oncology professionals in Europe. We invite you to save the date.
46.
 
CRRM — Innovations on Cancer Research and Regenerative Medicine
ID
875677
Dates
10 Sep 2017 - 13 Sep 2017
Location
Ho Chi Minh, Vietnam
Abstract
The 3rd CRRM, the international conference about Cancer Research and Regenerative Medicine co-organized by University of Science, VNU-HCM, Viet Nam; University of California, Los Angeles (UCLA), US; and MD Anderson Cancer Center, The University of Texas, US will be held at the University of Science, VNU-HCM, Ho Chi Minh on Sept 10-13, 2017. CRRM is an international forum for all scientists, researchers, doctors, students about cancer research and regenerative medicine. The conference consistently draws senior- and junior-level professionals from multiple sectors, providing a valuable combination of experience, enthusiasm, and varied perspectives to the discussions.
Contact
Phuc Van Pham;     Email: crrmconference@gmail.com
Topics
Cancer, Stem cell, Tissue engineering, Regenerative medicine, Tumor, Biomedical engineering, Biomedical Science
47.
 
Radiology in paediatric oncology - an update
ID
883796
Start date
22 Sep 2017
Location
London, United Kingdom
Abstract
This event will provide an update on the current major challenges faced by clinicians dealing with children who present with some of the commoner tumours of childhood, both from an oncology perspective but also from a radiological viewpoint. The speakers comprise some of the leading paediatric oncologists and radiologists from around the UK. The lecture topics include neuroblastoma, Wilms’ tumours, rhabdomyosaroma, osteosarcoma, and lymphomas plus sessions on functional imaging and interventional radiology in pediatric oncology. The day will finish with some interactive case sessions.
Contact
Malini Banerjee;     Phone: [02036682226];     Email: Malini.Banerjee@bir.org.uk
Topics
Oncology, paediatric, radiology, neuroblastoma, Wilms' tumours, tumour, rhadomyosaroma, osteosarcoma, lymphoma, leukaemia, interventional, imaging, diffusion weighted imaging.
Related subject(s)
48.
 
CANCER VAC — SMi's 6th annual Cancer Vaccines Conference
ID
903513
Dates
27 Sep 2017 - 28 Sep 2017
Location
London, United Kingdom
Abstract
SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2017 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 6th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more.
Contact
Kyra Williams;     Phone: [02078276012];     Email: kwilliams@smi-online.co.uk
Topics
Cancer vaccines; combination cancer immunotherapy; CAR, T-Cell; Dendritic Cells; Epitopes, Cancer, vaccine, combination therapies, adjuvants, chimeric antigen receptors, cells, immunotherapies, tumour, efficacy, delivery, therapeutic vaccines, immune monitoring, PDL-1, CTLA4, monoclonal antibodies, conference, London; tumour, immune, genetic heterogeneity, angiogenic, immune-oncology, oncology, rna, immunogen, immune, personalized therapy, protein, biomarker, disease, novel pathway, molecular, vaccinology, cell-based, liposomes, dna, peptide, vaccine
49.
 
EUS ENDO — EUS ENDO International Live Course
ID
850673
Dates
28 Sep 2017 - 29 Sep 2017
Location
Marseille, France
Abstract
EUS-ENDO will offer one day of live transmission from Paoli-Calmettes Institute to the Villa Méditerranée in the new center of Marseille. We have invited worldwide experts on EUS and Endoscopy, they will give lectures and will demonstrate the last developments of these technologies (ERCP, ESD, Therapeutic EUS, etc….) during the live demonstrations. New scopes will be showed as new accessories. The main goal of this meeting will be to demonstrate the complementarity of EUS and ERCP for bilio-pancreatic diseases, to show also new procedures as radiofrequency ablation of bilio-pancreatic cancers, cholangio-pancreatoscopy, confocal laser endomicrsocopy, etc…

The second day will be dedicated to hands on, 6 stations will be available for ERCP, EUS-FNA, T.EUS, GI bleeding management, EMR &ESD. This second day should be interactive between the participants and the experts, 4 workshops will be organized and also 3 sessions of oral communications in which participants will debate with the experts. Abstracts presented during EUS-ENDO will be published in Endoscopic Ultrasound review.

Contact
Sylvie Martel;     Phone: [+33 7 79 69 67 68];     Email: sylvie.martel@mcocongres.com
Topics
endoscopy, bilio-pancreatic diseases, cholangio-pancreatocopy, confocal laser endomicroscopy,
Related subject(s)
50.
 
Cancer Conferences, Cancer Meetings, Cancer Symposiums, Cancer Conferences USA — 2nd World Congress on Cancer Research & Therapy
ID
869121
Dates
02 Oct 2017 - 04 Oct 2017
Location
San Diego, United States
Abstract
On Tremendous success of our Cancer Congress-2016, The 2nd World Congress on Cancer Research & Therapy will take place in the gorgeous city of San Diego, USA in October 02-04, 2017 and the theme of the conference is “Aspiration, inspiration and imagination – Cancer research, Treatment and Care”. Cancer Congress-2017 is designed to be a relaxed and friendly meeting where delegates and invited speakers have a chance to interact on both a scientific and social basis. We encourage the speakers to stay for the duration of the conference to ensure this interaction.
Contact
Jason Clark;     Phone: [3373223608];     Email: cancer@innovincconferences.com
Topics
cancer conferences, cancer conferences usa, oncology conferences, cancer meetings, cancer symposiums, cancer nursing meetings, 2nd world congress on cancer, world cancer congress, cancer research conferences, cancer therapy conferences, world cancer research conference
Related subject(s)
51.
 
7th InterAmerican Oncology Conference
ID
814112
Dates
05 Oct 2017 - 06 Oct 2017
Location
Buenos Aires, Argentina
Abstract
The 7th. InterAmerican Oncology Conference "Current Status and Future of Anti-Cancer Targeted Therapies" will be held in Buenos Aires, Argentina in October 5th and 6th, 2017.

An outstanding faculty of speakers from the United States and Europe has committed in this meeting.

The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.

Contact
Email: oncology@oncologyconferences.com.ar
Topics
New Anticancer Therapies, Novel Agents in Early Clinical Trials, Melanoma, Breast Cancer, Immunotherapies, Biomarkers for Checkpoint Inhibitors, Genitourinary Cancer, Prostate cancer, Metastatic Renal Cell Carcinoma, Bladder Cancer, Gastrointestinal Cancer, Gastric Cancer, Colorectal cancer, Lung cancer, Mesothelioma, Hematological Malignancies, Leukemia, Multiple Myeloma, Lymphoma
Related subject(s)
52.
 
Defence is the Best Attack: Immuno-Oncology Breakthroughs
ID
898727
Dates
09 Oct 2017 - 11 Oct 2017
Location
Barcelona, Spain
Abstract
This new conference to be held in Barcelona, Spain, features an outstanding, internationally renowned faculty who will discuss their up-to-the-minute findings as well as roadmap the 'where to' in identifying novel targets, progressing our understanding of the mechanisms of action of therapeutic interventions, developing improved biomarkers of response to therapy, and overcoming mechanisms of intrinsic and acquired resistance to immunotherapy. With extensive networking opportunities, this conference will provide an intimate setting for top quality scientific interaction.
Contact
Laura Strachan;     Email: l.strachan@nottingham.ac.uk
Topics
immuno-oncology, immunotherapy, therapeutic, biomarkers, response, resistance, basic, translational, cancer, research, tumour, immune, immunoediting, checkpoints, microbioma
53.
 
Breast Cancer Conference — International Meeting on Women’s Health and Breast Cancer
ID
893984
Dates
12 Oct 2017 - 13 Oct 2017
Location
Osaka, Japan
Abstract
Meeting International welcomes every one of the members over the globe to attend International Meeting on Women's Health and Breast Cancer during October 12-13, 2017 in Osaka, Japan which incorporates incite keynote presentations, Oral talks, Poster presentations and Exhibitions.
Contact
Briana Wilson;     Phone: [+1-302-231-6756];     Email: breastcancer@meetingseries.org
Topics
Women, s Health, Breast Cancer, Cervical Cancer, Ovarian Cancer, Diabetes, Pregnancy, PCOD and Menstruation Irregularities.
Related subject(s)
54.
 
MAP : MOLECULAR ANALYSIS FOR PERSONALISED THERAPY
ID
841199
Dates
13 Oct 2017 - 14 Oct 2017
Location
Zurich, Switzerland
Abstract
A joint initiative of Cancer Research UK, UNICANCER and ESMO, this conference shines a light on the latest medical developments on molecular analysis for personalised therapy.
Contact
Patrick Wahby;     Email: map@overcome.eu
Topics
Cancer, cancer research UK, unicancer, esmo, molecular analysis, personalised therapy, genome, oncology, metastatic, clinical oncologists, scientific.
Event website
55.
 
TBCC9 — The International Tehran Breast Cancer Congress
ID
830824
Dates
18 Oct 2017 - 20 Oct 2017
Location
TEHRAN, Iran
Abstract
The International Tehran Breast Cancer Congress (ITBCC) provides a unique multidisciplinary setting for all professionals with a common interest in breast cancer to navigate, discuss, inform and educate themselves about this evolving disease landscape; to debate and deliberate about new data and developments; and to establish what it means for patient treatment and care.

Leading international and national scientists and physicians will address recent advances in breast cancer research, personalized therapy, and the latest clinical data impacting the treatment of breast cancer. Cutting-edge lectures, panel discussions, and interactive question-and-answer sessions will provide a unique opportunity for participants to engage with pioneers as they share their perspectives and personal experiences on the challenges and ongoing controversies in breast cancer.T

Contact
Secretariat;     Phone: [+9821-88673129];     Email: CONGRESS@IBCRC.IR
Topics
New concepts in Breast Cancer ; ( Epidemiology, Oncoplatic surgery & reconstruction, Screening & Prevention, Neoadjuvant & Adjuvant therapy, Radiotherapy, Imaging, Genetics & Heredity, Immunotherapy & Cell Therapy, Pathology, Quality of life, Ethical aspects, Medical informatics, Fertility preservation & Tissue engineering)
Related subject(s)
56.
 
Joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research
ID
764413
Dates
18 Oct 2017 - 21 Oct 2017
Location
Brisbane, Australia
Contact
Vivien Lietze;     Phone: [+4930204590];     Email: congress@worldmelanoma2017.com
Topics
Dermatology, Dermato-Oncology, Skin-Cancer, Melanoma
Related subject(s)
57.
 
2017 Novel Cancer Therapeutics Summit
ID
902459
Dates
19 Oct 2017 - 20 Oct 2017
Location
San Diego, United States
Abstract
We invite you to attend the 2017 Novel Cancer Therapeutics Summit, to be held on October 19-20, 2017 in San Diego, CA. This summit includes three parallel conferences focused on both the research, and business perspectives in oncology.
Contact
Kristen Starkey;     Phone: [6262566405];     Email: infogtcbio@gtcbio.com
Topics
emerging targets, therapeutic strategies, next generation sequencing in cancer diagnosis, progress in cancer immunotherapy, combination strategies in immuno-oncology, advancements in technology, as well as business development trends, markets, partnership opportunities, and access to capital market.
58.
 
ICOR 2017 — International Conference on Oncology and Radiology
ID
874910
Dates
23 Oct 2017 - 25 Oct 2017
Location
Las Vegas, United States
Abstract
The (ICOR 2017) Conference on Oncology and Radiology is an International Cancer Conference, a professional association that focuses on research in the field of Oncology. The aim of this association by constitution is to promote research in all fields of Cancer and related sciences, to encourage improvements in methods for the prevention and treatment of Cancer, to improve the health of the public through research, and to facilitate cooperation among investigators and the communication of research findings and their implications throughout the world. Plus, you'll have the opportunity to connect with more than 500 of your peers and celebrate your profession. You'll leave better educated and more invigorated than you thought possible. We wish to see you in Las Vegas, a promising place to discover novel things in the field of science and technology.
Contact
Michal Albert;     Phone: [+1 (702) 988 2320];     Email: cancer@magnusconferences.com
Topics
cancer conference, cancer conferences, cancer conferences 2017, oncology conference, oncology conferences, oncology conferences 2017, radiology conferences, global summit on oncology and radiology, oncology and radiology conferences 2017
Event website
59.
 
CoBrCa — 3rd World Congress on Controversies in Breast Cancer (CoBrCa)
ID
876649
Dates
26 Oct 2017 - 28 Oct 2017
Location
Tokyo, Japan
Abstract
The 3rd CoBrCa Congress will continue the tradition of directly addressing controversial issues in breast cancer faced by clinicians in their daily practice. The 3rd CoBrCa will focus on key issues in medical oncology, surgery, radiation oncology, reconstruction and pathology. The congress will provide a forum to effectively debate these unresolved clinical and therapeutic problems.
Contact
Secretariat;     Email: cobrca@congressmed.com
Topics
Breast cancer, oncology, Breast imaging, Breast reconstruction,
Related subject(s)
Event website
60.
 
Protecting the Code: Epigenetic Impacts on Genome Stability
ID
898682
Dates
29 Oct 2017 - 01 Nov 2017
Location
Berlin, Germany
Abstract
The maintenance of genome stability takes place in a chromatin environment, and it is increasingly evident that epigenetic regulation is a key component of genome stability. Notably, epigenetic pathways are frequently perturbed in cancer cells. Understanding the interplay between epigenetic regulation and genome stability at a molecular level is critical to cancer biology and has important translational implications. The programme will address the challenges of understanding this complex field and will emphasise new experimental systems for interrogating these pathways. While the emphasis is on understanding molecular mechanisms of epigenetic impacts on genome stability, we will also consider how recent advances can be exploited in the clinic.
Contact
Roger Doxat-Pratt;     Email: roger.doxat-pratt@nottingham.ac.uk
Topics
epigenetics, epigenetic, impacts, genome, genomes, stability, DNA, damage, signalling, chromatin, remodelling, histone, modifications, repair, replication, environment, regulation, non-coding, RNAs, Berlin, Harnack
61.
 
ABC4 — Advanced Breast Cancer Fourth ESO-ESMO International Consensus Conference
ID
893998
Dates
02 Nov 2017 - 04 Nov 2017
Location
Lisbon, Portugal
Abstract
ABC has established itself as a major international breast cancer conference. Its primary aim is the development of international consensus guidelines for the management of advanced breast cancer patients. These treatment guidelines are based on the most up-to-date evidence and can be used and adapted to many different health care settings globally.
Contact
Gabriele Maggini;     Phone: [+41918200950];     Email: communication@eso.net
Topics
Breast Cancer, Metastatic breast cancer, Advanced breast cancer, Metronomic chemotherapy
62.
 
ESGO 2017 Congress in Vienna — 20th Biennial International Meeting of the European Society of Gynaecological Oncology
ID
825922
Dates
04 Nov 2017 - 07 Nov 2017
Location
Vienna, Austria
Abstract
Held biennially, ESGO congress offers professionals in Gynaecological Oncology - including clinicians, researchers, residents and students a unique opportunity to learn and discuss the latest medical and scientific developments in gynaecological cancers research, treatment and care, as well as to network with key opinion leaders and peers from around the world.
Contact
Lucie Lamlova;     Email: lucie.lamlova@esgomail.org
Topics
the latest medical and scientific development, gynaecological cancers research, treatment and care
Related subject(s)
63.
 
EMBL Conference: Cancer Genomics
ID
834523
Dates
05 Nov 2017 - 08 Nov 2017
Location
Heidelberg, Germany
Abstract
This conference will provide an opportunity to learn about and keep up to date with the rapidly progressing area of cancer genomics. It will cover presentations from cancer genome projects, the areas of cancer functional genomics, systems biology, cancer mouse models and the translation and clinical impact of scientific results obtained. The meeting will bring together leading scientists from across these areas for a unique opportunity to interact and stimulate further integration of these efforts.

European Cancer Genomics research is particularly strong in the Heidelberg area, with three International Cancer Genome Consortium (www.icgc.org) projects being currently pursued with significant participation from Heidelberg institutions, including EMBL. As in our 2015 meeting, a large number of renowned speakers will be invited, with a strong representation of overseas speakers. The atmosphere at the conference will make this an exceptional event with cutting edge science, extensive scientific discussions and ample possibilities for meetings between and after sessions to facilitate in-depth discussions and new collaborations.

Contact
Phone: [4962213878797];     Email: marketing@embl.de
Related subject(s)
64.
 
NCRI — 2017 NCRI Cancer Conference
ID
882421
Dates
05 Nov 2017 - 08 Nov 2017
Location
Liverpool, United Kingdom
Abstract
The NCRI Cancer Conference is the largest annual cancer research meeting in the UK, attracting over 1,500 participants from across the spectrum of basic, translational and clinical research. We are committed to share and make available to all attendees the best cancer research from all over the world and encourage cross-pollination. The Conference provides a high profile platform where key stakeholders of cancer research come together to discuss, present and showcase high-quality research. The programme covers six main themes - Diagnosis and therapy, Epidemiology and prevention, Health services research, Information, patients and the public, Survivorship and end of life care and the cancer cell and model systems – which are organised in sessions across 4 days. The Conference programme includes plenty of networking opportunities, allowing participants to make the most of their time in Liverpool.
Contact
NCRI Conference and Events Team;     Phone: [+44 (0)20 3469 5453];     Email: ncriconference@ncri.org.uk
Topics
Cancer, basic science, translational research, clinical trials, clinical research, collaboration, share, knowledge, latest advances in cancer research, cancer research, diagnosis, therapy, epidemiology, prevention, health, health services, patients, consumers, patient experts, survivorship, end of life care, palliative care, living with and beyond cancer, cancer cell, cancer model systems, networking, abstract submission
65.
 
ICC2017 — 2nd Indian Cancer Congress
ID
833851
Dates
08 Nov 2017 - 12 Nov 2017
Location
BANGALORE, India
Abstract
The Indian Cancer congress is an amalgamation of the four major national oncology associations ( The Association of Radiation Oncologists of India, Indian Association of Surgical Oncology, the Indian Society of Medical & Pediatric Oncologists and the Indian Society of Oncology) . This conference is a planned quadrennial event of these four associations and all other sub specialty associations to improve the quality of cancer care through multidisciplinary interactionand will be held in various parts of the Indian subcontinent once every four years. The ICC2017 conference is scheduled to be held from 9th to 12th November 2017 (with pre-conference workshop held on 8th Nov 2017) in Bengaluru, India.The theme for the conference is “INSIGHT, INNOVATION, INTEGRATION” The field of oncology is rapidly evolving and is in constant flux. What is thought to be true today may very soon be turned on its head by new insights and new innovations. It is therefore prudent and necessary that we the oncology community – periodically stop in our fast tracks and take stock of some important insights and innovations and debate how best we can integrate these innovations into our practice. The congress hopes to attract each and everyone involved in the care of the cancer patient including physicians, basic scientists, patients, survivors , care givers, researchers, investors etc and to provide a platform from which meaningful value addition can emerge.
Contact
Nalini Rao;     Phone: [9845517681];     Email: nkrao@hotmail.com
66.
 
14. AIO-Herbstkongress
ID
873098
Dates
16 Nov 2017 - 18 Nov 2017
Location
Berlin, Germany
Abstract
Vom 16. bis 18. November 2017 findet der 14. AIO-Herbstkongress „Update Medical Oncology“ im Hotel Pullman Berlin Schweizerhof statt. Wie schon in den vergangenen Jahren steht der Kongress ganz im Zeichen der klinischen Forschungsarbeit des Themenbereiches der soliden Tumoren und der Translationalen Forschung. Der AIO-Herbstkongress wird inhaltlich von den Arbeits- und Studiengruppen der AIO gestaltet und befasst sich schwerpunktmäßig mit dem wissenschaftlichen Update dieser Studienaktivitäten. Das Format des AIO-Herbstkongresses mit seinen Plenar- und Gruppensitzungen, Symposien und Diskussionsrunden hat sich bewährt, was nicht zuletzt an den steigenden Teilnehmerzahlen und einer umfangreichen begleitenden Industrieausstellung ersichtlich ist.
Contact
Andreas Kandler;     Phone: [+49 (0)89 549096-77];     Email: aio-herbstkongress@mci-group.com
Topics
Mammakarzinom und Gynäkologische Tumoren, Ösophagus-/Magenkarzinom, Kolon-/Rektum-/Dünndarmtumoren, Weichteilsarkome/Knochentumoren, Thorakale Onkologie, Urogenitaltumoren
67.
 
Innovate Cancer 2017 — Cancer Research
ID
875540
Dates
27 Nov 2017 - 28 Nov 2017
Location
Brisbane, Austria
Abstract
The 2017 Innovate Cancer Research Conferences are a hub that covers the core aspects of Pathophysiology including “Oncology and Cancer Therapy, Blood Cancer, Prostate Cancer, Thyroid Cancer, Breast Cancer, Cervical Cancer, Pancreatic Cancer, Oral Cancer, Gynecologic Oncology, Brain Cancer, Organ specific cancers
Contact
aarondurant;     Phone: [61-1-800-025-686];     Email:  Cancer@innovatecolloquiums.com
68.
 
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
898024
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, United Kingdom
Abstract
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Safina Robinson;     Phone: [18009820387];     Email: biomarkers@cmesocietyconferences.org
Topics
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conference 2017, Biomarkers Society Conferences, Biomarkers conference
69.
 
Biomarkers Congress 2017 — Annual World Congress on Biomarkers & Clinical Research
ID
884468
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, United States
Abstract
PULSUS brings in a new spin on conferences by presenting the latest scientific improvements in Biomarkers and its clinical researches. Listen to motivating keynotes from thought leaders, pioneers across the globe. Atlanta is all set for an amazing event as PULSUS proudly presents the “Annual World Congress on Biomarkers & Clinical Research” on November 27-28, 2017. PULSUS cordially welcome researchers, academicians, students and business professionals in the field of BIOMARKERS from around the world to participate in the upcoming BIOMARKERS CONGRESS 2017. The meeting for this year will revolve around the theme “Explore the latest Biomarkers development in health and clinical research” thus relaying the most cutting edge findings in the field of Biomarkers Research.
Contact
Safina Robinson;     Phone: [+1-800-982-0387];     Email: biomarkers@cmesocietyconferences.org
Topics
Biomarker Conference, Biomarkers Conference 2017, Biomarkers Conferences, Biomarkers Congress, Biomarker Conferences USA, Biomarker Conferences, Biomarkers Congress 2017, Biomarker Conferences 2017, Biomarkers Society Conferences, Biomarkers cme conference
70.
 
Oncology Summit 2017 — International Oncology Summit
ID
902433
Dates
27 Nov 2017 - 28 Nov 2017
Location
Atlanta, United States
Abstract
Allied Academies invites all the participants from all over the world to attend 'International Oncology Summit’ during November 27-28, 2017 in Atlanta, Georgia, USA which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions. This Summit has the platform to fulfill the prevailing gaps in the transformation of this science of hope, to serve promptly with solutions to all in the need. International Oncology Summit will have an anticipated participation of 120+ delegates across the world to discuss the conference goal
Contact
Rayan Wayne;     Phone: [8008582189];     Email: oncologyevents@alliedconferences.org
Topics
Cancer Conferences USA, Cancer Meetings 2017, Oncology Conferences USA, Oncology Symposiums 2017, Oncology Conferences Atlanta.
Related subject(s)
71.
 
1st joint EACR-MRS Conference on Seed and Soil: In Vivo Models of Metastasis
ID
898703
Dates
27 Nov 2017 - 29 Nov 2017
Location
Berlin, Germany
Abstract
We are pleased to invite you to join us at the 1st joint EACR-MRS Conference on Seed and Soil: In Vivo Models of Metastasis. Metastasis is responsible for over 90% of cancer patient deaths, largely due to the fact that therapies are generally ineffective against detectable metastatic tumours. This conference aims to address the crucial need to better understand the metastatic process in order to identify effective therapeutic strategies.
Contact
Laura Strachan;     Email: l.strachan@nottingham.ac.uk
Topics
metastasis, in-vivo, models, imaging, transgenic, modelling, MRS, therapeutic, strategies, tools, world-leading, latest, cancer, research
72.
 
WCC-2017 — World Cancer Conference
ID
898572
Dates
29 Nov 2017 - 30 Nov 2017
Location
Florida, United States
Contact
Carol Smith;     Phone: [8005204889];     Email: carolsmith.oap@gmail.com
Topics
Breast Cancer  Colorectal Cancer Lymphoma  Lung Cancer  Blood Cancer Gynecologic cancer  Cancer Treatment and Prevention Herbal Treatments for Cancer Stem Cell Transplants Cancer Diagnosis Cancer Biomarkers Metastatic Cancer  Cancer Genomics Skin cancer
73.
 
Global Cancer Meet and Expo
ID
900998
Dates
04 Dec 2017 - 06 Dec 2017
Location
Dubai, United Arab Emirates
Abstract
Linkin Science, welcomes you all to the Global Cancer Meet and Expo, with the theme “Advanced insights in Cancer Therapeutics” which will be hosted in Dubai during December 04th - 06th, 2017.
Contact
Daniel Becker;     Phone: [+1 (415) 463-8448 ];     Email: cancermeet@linkinscience.com
Topics
Cancer therapeutics, Cancer Diagnostics, Cancer Immunology, Clinical Research in Cancer, Metastatic carcinoma, OncoGenomics, Cell Biology and Cancer, Cancer stem cells and drug resistance, Breast cancer, Prostate Cancer, Lung Cancer, Other major cancer types, Cancer Prognosis, Cancer prevention and Management
74.
 
Focal 2017 — 10th International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer
ID
873666
Dates
11 Feb 2018 - 13 Feb 2018
Location
Noordwijk, Netherlands
Abstract
The “10th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer” will be he held in Noordwijk - Amsterdam, The Netherlands, on February 11th -13th, 2018. The Symposium was initiated in 2008 and ever since it has been rotating between the USA and Amsterdam. This year’s Symposium is organized by Prof. Jean De la Rosette and his team at the AMC University Hospital in Amsterdam in collaboration with the Department of Urology of Duke University in Durham, NC and the USC Institute of Urology in Los Angeles, CA in the USA.
Contact
Email: focal@focaltherapy.org
Related subject(s)
75.
 
DDRC — 3rd DNA Replication/Repair Structures and Cancer - Fusion Conferences
ID
884641
Dates
11 Feb 2018 - 15 Feb 2018
Location
Cancun, Mexico
Abstract
Join scientific chairs Prof. Tom Blundell (University of Cambridge) and Prof. John Tainer (LBL & MD Anderson Cancer Center) in Cancun for the third conference in this series, described by Prof. Ben Van Houten from University of Pittsburgh: ‘I can honestly say your meeting, by combining hard core structure-function studies with beautiful biology, hits an important area that many meetings miss; being part of that science is just terrific.’
Contact
Laura Trundle;     Phone: [01638 724137];     Email: laura@fusion-conferences.com
Topics
DNA replication, DNA repair, DNA damage, cancer, replication complexes, mutational signatures, kataegis, synthetic lethality, chromatin, chromosome instability, epigenetics, PARP, PARG, metabolic signaling, mitochondrial replication, mitochondrial repair, RNA damage responses, apoptosis
Related subject(s)
76.
 
Fusion Conferences — Nuclear Receptors (New Roles for Nuclear Receptors in Development, Health and Disease) - Fusion conference
ID
897897
Dates
27 Feb 2018 - 02 Mar 2018
Location
Cancun, Mexico
Abstract
Join scientific chairs Charlotte Bevan (Professor of Cancer Biology, Imperial College London), Karen Knudsen (Sidney Kimmel Cancer Center, TJU, Thomas Jefferson University) and Simak Ali (Principal Investigator, Imperial College London) at the Nuclear Receptors (New Roles for Nuclear Receptors in Development, Health and Disease) Fusion conference in Mexico.
Contact
Sarah Trundle;     Phone: [01638 724137];     Email: sarah@fusion-conferences.com
Topics
nuclear receptors, physiologically, pharmacologically, ageing, aging, DNA damage repair pathways, therapeutic target, steroid signalling, estrogen receptor, antiestrogens, androgen, aromatase inhibitors, transcriptional processes, drug development, health, disease, cancer, glucocorticoid receptor, nuclear receptor, crosstalk, epigenetic control, epigenetic regulation, circadian rhythms, cellular pathways, breast cancer, NR-targeting, prostate cancer, small molecules, non coding RNA, DNA damage, cell cycle, metabolism, metabolic disease, CNS, Endocrinology, Oncology, Paediatrics, Urology, Gynaecology, Obstetric Medicine, Neuroscience, Cardiology.
Related subject(s)
77.
 
48. Kongress der Deutschen Gesellschaft für Endoskopie und Bildgebende Verfahren e.V.
ID
903293
Dates
15 Mar 2018 - 18 Mar 2018
Location
Munich, Germany
Contact
Martina Wiederkrantz;     Phone: [089 8906770];     Email: martina.wiederkrantz@cocs.de
Related subject(s)
Event website
78.
 
Cancer Imaging and Therapy
ID
836395
Dates
02 Apr 2018 - 06 Apr 2018
Location
Hollywood, United States
Abstract
The Cancer Imaging and Therapy conference will focus on optical methods in cancer, centered on imaging and treatment of cancer. The conference will accept submissions on topics on the molecular and cellular level, such as reporters and theranostics; on the tissue and pre-clinical (animal) level, such as pathology methods and advances in imaging of tumor models; and on human tissue and living human subjects, when specifically dealing with cancer. More generic biomedical optics and biophotonics research involving human tissues or living human subjects should be submitted to the Clinical and Translational Biophotonics conference at this congress.

Good to know...

You can advertise your event or services in this space.

Last updated: 27 April 2017